Evommune Looks To Advance Broad Pipeline Of Autoimmune Drugs
Executive Summary
Emerging Company Profile: With experienced leadership and new financing, Evommune is developing a topical IRAK4 inhibitor for atopic dermatitis and earlier-stage systemic drugs for various conditions.